Skip to main content
. 2024 May 23;81(1):233. doi: 10.1007/s00018-024-05269-1

Fig. 3.

Fig. 3

Enumeration of circulating tumour cell (CTC) counts in (A) in all head and neck squamous cell carcinoma (HNSCC) patients based on their tumour stage. (B) in all HNSCC patients based on their nodal stage. (C) in all P16 positive oropharyngeal squamous cell carcinoma (OPSCC) patients based on their tumour stage. (D) in P16 positive OPSCC patients based on their nodal stage. (E) in other HNSCC patients based on their tumour stage. (F) in other HNSCC patients based on their nodal stage. P-values are based on a comparison to Poisson rates using generalized regression, ns p > 0.050, * p < 0.050, ** P < 0.010